IN2015DN01616A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01616A IN2015DN01616A IN1616DEN2015A IN2015DN01616A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A IN 1616DEN2015 A IN1616DEN2015 A IN 1616DEN2015A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A
- Authority
- IN
- India
- Prior art keywords
- tissue
- cells
- cell formulation
- myocardial
- pluripotent stem
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012181029 | 2012-08-17 | ||
| PCT/JP2013/054049 WO2014027474A1 (ja) | 2012-08-17 | 2013-02-19 | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
| PCT/JP2013/071981 WO2014027684A1 (ja) | 2012-08-17 | 2013-08-15 | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01616A true IN2015DN01616A (pt) | 2015-07-03 |
Family
ID=50685515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1616DEN2015 IN2015DN01616A (pt) | 2012-08-17 | 2013-08-15 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US9844570B2 (pt) |
| EP (2) | EP3659612B1 (pt) |
| JP (1) | JP5968442B2 (pt) |
| KR (1) | KR101730052B1 (pt) |
| CN (1) | CN104582711B (pt) |
| AU (1) | AU2013303492B2 (pt) |
| CA (1) | CA2882239C (pt) |
| DK (1) | DK2886123T3 (pt) |
| ES (1) | ES2767182T3 (pt) |
| IN (1) | IN2015DN01616A (pt) |
| PL (1) | PL2886123T3 (pt) |
| PT (1) | PT2886123T (pt) |
| SG (2) | SG10201800829XA (pt) |
| WO (2) | WO2014027474A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014027474A1 (ja) | 2012-08-17 | 2014-02-20 | 株式会社Ｃｌｉｏ | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
| JP2015160820A (ja) * | 2014-02-26 | 2015-09-07 | 株式会社Ｃｌｉｏ | 慢性腎障害治療のための多能性幹細胞 |
| JP6452107B2 (ja) | 2014-09-05 | 2019-01-16 | 国立大学法人 東京大学 | 糖尿病性皮膚潰瘍治療のための多能性幹細胞 |
| WO2016168993A1 (en) * | 2015-04-22 | 2016-10-27 | Innolife Co., Ltd. | Methods of tissue repair and regeneration |
| JP6770673B2 (ja) * | 2016-02-26 | 2020-10-21 | 国立大学法人東海国立大学機構 | 急性心筋梗塞の予後マーカー及びその利用 |
| AU2017287529B2 (en) * | 2016-07-01 | 2022-11-10 | Life Science Institute, Inc. | Prophylactic or therapeutic agent for organ fibrosis |
| US11419899B2 (en) | 2016-07-29 | 2022-08-23 | Tohoku University | Method of treating aortic aneurysm using muse cells |
| EP3494978A4 (en) * | 2016-08-03 | 2020-03-11 | National University Corporation Nagoya University | IMPROVEMENT AND TREATMENT OF CHRONIC PULMONARY DISEASES USING PLURIPOTENT STEM CELLS |
| KR102464099B1 (ko) * | 2016-08-03 | 2022-11-08 | 히로시 야부키 | 다능성 간세포에 의한 허혈재관류 폐장애의 경감 및 치료 |
| CN109661461B (zh) | 2016-08-03 | 2024-05-24 | 株式会社生命科学研究院 | 在体外分化诱导多能性干细胞的方法 |
| CN106822899B (zh) * | 2017-03-10 | 2020-11-27 | 北京大学 | 一种通过抑制自噬促进心肌再生的药物 |
| CA3079500A1 (en) * | 2017-10-17 | 2019-04-25 | Hiroshima University | Pluripotent stem cells inducing osteochondral repair |
| JP7102666B2 (ja) * | 2018-01-25 | 2022-07-20 | 国立大学法人東海国立大学機構 | Ｍｕｓｅ細胞動員剤及び心筋障害への利用 |
| JP7072777B2 (ja) * | 2018-07-03 | 2022-05-23 | 株式会社生命科学インスティテュート | 慢性腎障害治療のための多能性幹細胞 |
| CN110302212A (zh) * | 2019-07-17 | 2019-10-08 | 陶正博 | 一种用于治疗急性心肌梗死的细胞制剂及其制备方法 |
| KR20220003564A (ko) | 2019-08-19 | 2022-01-10 | 세루아쿠시아 가부시키가이샤 | 세포 함유 의약 조성물 |
| US20220323509A1 (en) * | 2019-09-05 | 2022-10-13 | Tohoku University | Therapeutic agent for myocarditis |
| US20220387507A1 (en) * | 2019-10-31 | 2022-12-08 | Life Science Institute, Inc. | Therapy for interstitial cystitis by pluripotent stem cells |
| JPWO2021201286A1 (pt) | 2020-04-02 | 2021-10-07 | ||
| JP2021073305A (ja) * | 2021-02-09 | 2021-05-13 | 株式会社生命科学インスティテュート | 慢性腎障害治療のための多能性幹細胞 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994000484A1 (en) * | 1992-06-22 | 1994-01-06 | Young Henry E | Scar inhibitory factor and use thereof |
| US6387369B1 (en) * | 1997-07-14 | 2002-05-14 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
| AU5545499A (en) * | 1998-07-31 | 2000-02-21 | Genzyme Corporation | Improvement of cardiac function by mesenchymal stem cell transplantation |
| US20020098167A1 (en) | 2000-07-31 | 2002-07-25 | Piero Anversa | Methods and compositions for the repair and/or regeneration of damaged myocardium |
| CA2434362A1 (en) * | 2001-01-20 | 2002-07-25 | Cardion Ag | Pluripotent adult stem cells derived from regenerative tissue |
| KR101073411B1 (ko) | 2001-07-12 | 2011-10-17 | 제론 코포레이션 | 인간 다분화능 줄기 세포로부터 제조된 심근 세포 계통의 세포 |
| JP5103626B2 (ja) | 2005-01-27 | 2012-12-19 | 財団法人ヒューマンサイエンス振興財団 | 間葉系幹細胞を含む細胞シート |
| EP2206724A1 (en) | 2005-12-13 | 2010-07-14 | Kyoto University | Nuclear reprogramming factor |
| CN101517069A (zh) * | 2006-07-13 | 2009-08-26 | 塞拉帝思股份公司 | 由人类胚泡来源的干细胞衍生的多能心脏前体细胞新种群 |
| WO2009046058A1 (en) * | 2007-10-01 | 2009-04-09 | University Of Miami | A method to amplify cardiac stem cells in vitro and in vivo |
| US8465733B2 (en) | 2007-11-02 | 2013-06-18 | Jcr Pharmaceuticals Co., Ltd. | Pharmaceutical composition containing human mesenchymal stem cell |
| JP5564679B2 (ja) * | 2009-04-16 | 2014-07-30 | 公益財団法人ヒューマンサイエンス振興財団 | 心筋細胞分化誘導促進剤およびその使用方法 |
| US9550975B2 (en) * | 2009-07-15 | 2017-01-24 | Mari Dezawa | SSEA-3 pluripotent stem cell isolated from body tissue |
| WO2012054501A1 (en) * | 2010-10-18 | 2012-04-26 | Sunshine Biotech Inc. | Human multipotent embryonic stem cell-like progenitor cells |
| WO2014027474A1 (ja) | 2012-08-17 | 2014-02-20 | 株式会社Ｃｌｉｏ | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
-
2013
- 2013-02-19 WO PCT/JP2013/054049 patent/WO2014027474A1/ja active Application Filing
- 2013-08-15 KR KR1020157006629A patent/KR101730052B1/ko active IP Right Grant
- 2013-08-15 JP JP2014530568A patent/JP5968442B2/ja active Active
- 2013-08-15 CN CN201380043649.5A patent/CN104582711B/zh active Active
- 2013-08-15 DK DK13879518.2T patent/DK2886123T3/da active
- 2013-08-15 US US14/421,754 patent/US9844570B2/en active Active
- 2013-08-15 ES ES13879518T patent/ES2767182T3/es active Active
- 2013-08-15 PT PT138795182T patent/PT2886123T/pt unknown
- 2013-08-15 EP EP19202650.8A patent/EP3659612B1/en active Active
- 2013-08-15 EP EP13879518.2A patent/EP2886123B1/en active Active
- 2013-08-15 CA CA2882239A patent/CA2882239C/en active Active
- 2013-08-15 SG SG10201800829XA patent/SG10201800829XA/en unknown
- 2013-08-15 PL PL13879518T patent/PL2886123T3/pl unknown
- 2013-08-15 AU AU2013303492A patent/AU2013303492B2/en not_active Ceased
- 2013-08-15 IN IN1616DEN2015 patent/IN2015DN01616A/en unknown
- 2013-08-15 SG SG11201501185WA patent/SG11201501185WA/en unknown
- 2013-08-15 WO PCT/JP2013/071981 patent/WO2014027684A1/ja active Application Filing
-
2017
- 2017-11-03 US US15/802,899 patent/US10376544B2/en active Active
-
2019
- 2019-06-25 US US16/452,376 patent/US10639335B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150043482A (ko) | 2015-04-22 |
| PL2886123T3 (pl) | 2020-05-18 |
| US20150196600A1 (en) | 2015-07-16 |
| US20190307806A1 (en) | 2019-10-10 |
| JP5968442B2 (ja) | 2016-08-10 |
| AU2013303492A1 (en) | 2015-03-12 |
| CA2882239C (en) | 2018-05-22 |
| AU2013303492B2 (en) | 2017-02-16 |
| EP3659612B1 (en) | 2023-06-07 |
| EP3659612A1 (en) | 2020-06-03 |
| CA2882239A1 (en) | 2014-02-20 |
| WO2014027684A1 (ja) | 2014-02-20 |
| CN104582711B (zh) | 2019-12-06 |
| EP2886123A1 (en) | 2015-06-24 |
| PT2886123T (pt) | 2020-01-22 |
| ES2767182T3 (es) | 2020-06-16 |
| EP2886123A4 (en) | 2016-06-22 |
| US9844570B2 (en) | 2017-12-19 |
| EP2886123B1 (en) | 2019-10-23 |
| WO2014027474A1 (ja) | 2014-02-20 |
| US10639335B2 (en) | 2020-05-05 |
| US10376544B2 (en) | 2019-08-13 |
| CN104582711A (zh) | 2015-04-29 |
| DK2886123T3 (da) | 2020-01-27 |
| SG10201800829XA (en) | 2018-03-28 |
| SG11201501185WA (en) | 2015-05-28 |
| JPWO2014027684A1 (ja) | 2016-07-28 |
| US20180050067A1 (en) | 2018-02-22 |
| KR101730052B1 (ko) | 2017-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01616A (pt) | ||
| NZ623454A (en) | Pharmaceutical composition for the treatment of heart diseases | |
| MX2016005574A (es) | Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel. | |
| BR112014010776A8 (pt) | neurônios dopaminérgicos (da) mesencefálicos para enxerto | |
| AU2009240884A8 (en) | Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation | |
| MX340275B (es) | Metodos, sistema y aparato para la deteccion, diagnostico y tratamiento de trastornos del ritmo biologico. | |
| ES2721180T3 (es) | Productos terapéuticos usando células adiposas y secreciones celulares | |
| MX340185B (es) | Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca. | |
| BR112014012972A2 (pt) | composição de meio de cultura para rejuvenscer células-tronco | |
| ES2572211T3 (es) | Regeneración de músculo esquelético utilizando células madre mesenquimales | |
| ES2685319T3 (es) | Generación de células marcapasos basada en factor de transcripción y métodos de uso de las mismas | |
| JP2014509319A5 (pt) | ||
| Vawda et al. | Current stem cell treatments for spinal cord injury | |
| WO2014183033A3 (en) | G-csf for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal | |
| EA201490995A1 (ru) | Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток | |
| SG11201900986YA (en) | Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells | |
| CA2904533C (en) | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | |
| Gui-xian et al. | Therapeutic effects of umbilical cord mesenchymal stem cells transplantation on systemic lupus erythematosus | |
| WO2014072720A3 (en) | Cell differentiation | |
| SG11201810188VA (en) | Amelioration and treatment of perinatal brain damage with pluripotent stem cells | |
| SG11201900983TA (en) | Amelioration and treatment of chronic lung disease using pluripotent stem cells | |
| WO2012169897A8 (en) | Weight reducing material | |
| WO2014063035A3 (en) | Treatment of pain using amnion derived adherent cells | |
| UA100881U (uk) | Засіб для відновлення уражених тканин організму людини | |
| PL418104A1 (pl) | Sposób odnowy tkankowej z wykorzystaniem komórek regenerujących |